Medicinal composition containing fbpase inhibitor

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/675 (2006.01) A61K 31/427 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2591416

Means for the treatment of diabetes which has the high ability to reduce the blood sugar level and is effective in alleviating pancreatic .beta.-cell dysfunction. It is a medicine comprising a combination of an FBPase inhibitor and an insulin resistance reducer which is 5-[4-(6-methoxy-1-methyl-1H- benzoimidazol-2-ylmethoxy)~benzyl]thiazolidine-2,4-dione or a pharmacologically acceptable salt thereof.

La présente invention concerne un moyen de traitement du diabète doté d'une haute capacité à réduire la glycémie et qui est efficace pour réduire le dysfonctionnement des cellules .beta. du pancréas. Le médicament décrit dans l~invention comprend l'association d~un inhibiteur de la FBPase et d~un réducteur de résistance à l~insuline qui est la 5-[4-(6-méthoxy-1-méthyl-1H-benzoimidazol-2-ylméthoxy)­benzyl]thiazolidine-2,4-dione ou un sel pharmacologiquement acceptable de celle-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Medicinal composition containing fbpase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicinal composition containing fbpase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicinal composition containing fbpase inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1404068

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.